Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A broad classification for humoral immunodeficiencies. These disorders may be caused by inadequate activation of progenitor B cells, defective class-switching or the effects of medications. Despite the potential for increased susceptibility to infection, these disorders are self-limited with eventual normalization of serum antibody levels.
Biomarker and diagnostic research for transient hypogammaglobulinemia has been reported in the published literature.
No clinical trials have been registered for transient hypogammaglobulinemia.
13 publications have been identified in PubMed for transient hypogammaglobulinemia. Research spans Review / Meta-Analysis (38%), Epidemiology / Natural History (31%), and Other (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 5 | 38% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:45 AM UTC
4 |
31% |
Other research | 1 | 8% |
Testing and diagnosis research | 1 | 8% |
Clinical study results | 1 | 8% |
New treatment approaches | 1 | 8% |
Ozkan E (2026). [PMID: 41712476](https://pubmed.ncbi.nlm.nih.gov/41712476/). *Int Arch Allergy Immunol*. [Epidemiology / Natural History]
Justiz Vaillant AA (2026). [PMID: 31335076](https://pubmed.ncbi.nlm.nih.gov/31335076/). *Unknown Journal*. [Review / Meta-Analysis]
Öztürk G (2026). [PMID: 42096373](https://pubmed.ncbi.nlm.nih.gov/42096373/). *Int Arch Allergy Immunol*. [Diagnostic / Biomarker]
Keskindemirci G (2026). [PMID: 41724721](https://pubmed.ncbi.nlm.nih.gov/41724721/). *Scand J Immunol*. [Review / Meta-Analysis]
Justiz Vaillant AA (2026). [PMID: 29939682](https://pubmed.ncbi.nlm.nih.gov/29939682/). *Unknown Journal*. [Other]
Kose H (2026). [PMID: 41705238](https://pubmed.ncbi.nlm.nih.gov/41705238/). *Front Immunol*. [Epidemiology / Natural History]
Bestas B (2025). [PMID: 40171248](https://pubmed.ncbi.nlm.nih.gov/40171248/). *RSC Chem Biol*. [Gene Therapy / Novel Therapeutics]
Demirtaş Güner D (2025). [PMID: 40270942](https://pubmed.ncbi.nlm.nih.gov/40270942/). *Front Pediatr*. [Epidemiology / Natural History]
Ameratunga R (2025). [PMID: 41324804](https://pubmed.ncbi.nlm.nih.gov/41324804/). *Clin Rev Allergy Immunol*. [Review / Meta-Analysis]
Celiksoy MH (2025). [PMID: 40380357](https://pubmed.ncbi.nlm.nih.gov/40380357/). *Allergy Asthma Proc*. [Epidemiology / Natural History]